Clinical Drug with Continuous Dose Form

Overview

Clinical drugs representing a continuous dose form are modeled using concentration strength attributes. Clinical drugs with a continuous dose form using concentration strength represents a medicinal product based on description of 1) its precise active ingredient substances only and explicitly, 2) the stated basis of strength substance(s) with strength, expressed as concentration strength and 3) with its manufactured dose form (with the exception of reconstituted oral liquid preparations, where the administrable dose form is be used as it is the most clinically relevant).

This is used for product types such as cutaneous semi-solids (without metered actuation), solutions, suspensions, creams, ointments, bulk powders and granules, topical liquids (without metered actuation) including drops, oral liquids, nebuliser liquids and liquid parenteral products.

For example,

  • Product containing precisely zidovudine 10 milligram/1 milliliter conventional release oral solution (clinical drug)

  • Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug)

  • Product containing precisely clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)

  • Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment (clinical drug)

Modeling

Stated parent

763158003 |Medicinal product (product)|

Semantic tag

(clinical drug)

Definition status

Defined

Exception:

  • Concepts with product strength that is "not equal to" (e.g. with product strength expressed as a range, greater than, or less than) are primitive

Attribute:

Has manufactured dose form

Range: 736542009

Attribute:

Count of base of active ingredient (attribute)

Concrete Type: Integer

Range: >#0..

Cardinality: 1..1

Relationship group

One relationship group containing one instance of each of the following attributes is required for each precise active ingredient.

  • Has precise active ingredient

Range: <105590001

  • Has basis of strength substance

Range: <105590001

  • Has concentration strength numerator value

Concrete Type: Decimal

Range: >#0..

Cardinality: 1..1 per relationship group

  • Has concentration strength numerator unit

Range: <767524001

  • Has concentration strength denominator value

Concrete Type: Decimal

Range: >#0..

Cardinality: 1..1 per relationship group

For this pattern, the attribute value must be 1.

The denominator strength value is required for concepts in the International Release even though the value = 1, because including denominators for only some concepts negatively affects the classification results.

  • Has concentration strength denominator unit

Range: <767524001

Naming

Use one of the following patterns for the FSN and PT.

FSN

Where Precise active ingredient = BoSS:

  • Product containing precisely <BoSS FSN> <Concentration strength numerator value FSN> <Concentration strength numerator unit FSN>/<Concentration strength denominator value FSN> <Concentration strength denominator unit FSN> <Manufactured dose form FSN> (clinical drug)

For example,

  • Product containing precisely amitriptyline hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)

  • Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)

  • Product containing precisely clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)

  • Product containing precisely zidovudine 10 milligram/1 milliliter conventional release oral solution (clinical drug)

  • Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug)\

Where Precise active ingredient is not = BoSS:

  • Product containing precisely <BoSS FSN> (as <Precise active ingredient FSN>) <Concentration strength numerator value FSN> <Concentration strength numerator unit FSN>/<Concentration strength denominator value FSN> <Concentration strength denominator unit FSN> <Manufactured dose form FSN> (clinical drug)

For example,

  • Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug)

  • Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment (clinical drug)

Preferred Term

Where Single ingredient with BoSS = Precise active ingredient:

  • <BoSS PT> <Concentration strength numerator value PT> <Concentration strength numerator unit PT>/<Concentration strength denominator value PT> <Concentration strength denominator unit PT> <Manufactured dose form PT>

For example,

  • Amitriptyline hydrochloride 5 mg/mL oral solution

  • Buprenorphine 70 microgram/hour prolonged-release transdermal patch

  • Clotrimazole 10 mg/g cutaneous cream

  • Zidovudine 10 mg/mL oral solution

  • Lopinavir 80 mg/mL and ritonavir 20 mg/mL oral solution

Where Single ingredient with BoSS is not = Precise active ingredient:

  • <BoSS PT> (as <Precise active ingredient PT>) <Concentration strength numerator value PT> <Concentration strength numerator unit PT>/<Concentration strength denominator value PT> <Concentration strength denominator unit PT> <Manufactured dose form PT>

For example,

  • Amikacin (as amikacin sulfate) 250 mg/mL solution for injection

  • Mupirocin (as mupirocin calcium) 20 mg/g nasal ointment

Synonym

Synonyms converting metric units to percent or parts per millions may be included for medical gas concepts (e.g. Helium 79% and oxygen 21% gas for inhalation, Helium 790,000 ppm and oxygen 210,000 ppm gas for inhalation).

Exemplars

Stated template view

Example Concepts

Stated view for 781834001 |Product containing precisely digoxin 250 microgram/1 milliliter conventional release solution for injection (clinical drug)|
Inferred view for 781834001 |Product containing precisely digoxin 250 microgram/1 milliliter conventional release solution for injection (clinical drug)|-
Stated view for 769821007 |Product containing precisely digoxin 50 microgram/1 milliliter conventional release oral solution (clinical drug)|
Inferred view for 769821007 |Product containing precisely digoxin 50 microgram/1 milliliter conventional release oral solution (clinical drug)|.
Stated view for 396279000 |Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)|.
Inferred view for 396279000 |Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)|
Stated view for 769514000 |Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)|
Inferred view for 769514000 |Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)|.

Provide Feedback

Last updated